Adam Cuker

Adam Cuker

University of Pennsylvania

H-index: 57

North America-United States

About Adam Cuker

Adam Cuker, With an exceptional h-index of 57 and a recent h-index of 46 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Hematology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficacy and Safety of Fidanacogene Elaparvovec in Adults with Moderately Severe or Severe Hemophilia B: Results from the Phase 3 BENEGENE-2 Gene Therapy Trial

Confidence score: a data-driven measure for inclusive systematic reviews considering unpublished preprints

Expert consensus on an algorithm for rapid exclusion of clinically relevant plasma levels of direct oral anticoagulants in patients using the DOAC Dipstick

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Diversity, equity, and inclusion in ASH guidelines

Laboratory monitoring of heparin anticoagulation in hemodialysis: Rationale and strategies

Cost-effectiveness of rapid vs. in-house vs. send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura

Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice

Adam Cuker Information

University

Position

Assistant Professor of Medicine

Citations(all)

16434

Citations(since 2020)

11248

Cited By

8854

hIndex(all)

57

hIndex(since 2020)

46

i10Index(all)

155

i10Index(since 2020)

136

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

Adam Cuker Skills & Research Interests

Hematology

Top articles of Adam Cuker

Title

Journal

Author(s)

Publication Date

Efficacy and Safety of Fidanacogene Elaparvovec in Adults with Moderately Severe or Severe Hemophilia B: Results from the Phase 3 BENEGENE-2 Gene Therapy Trial

Hämostaseologie

R Klamroth

A Cuker

H Alzahrani

J Astermark

L Frenzel

...

2024/2

Confidence score: a data-driven measure for inclusive systematic reviews considering unpublished preprints

Jiayi Tong

Chongliang Luo

Yifei Sun

Rui Duan

M Elle Saine

...

2024/4/1

Expert consensus on an algorithm for rapid exclusion of clinically relevant plasma levels of direct oral anticoagulants in patients using the DOAC Dipstick

Hämostaseologie

J Harenberg

R Gosselin

I Pabinger

C Becattini

A Cuker

...

2024/2

Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

Azita H Talasaz

Parham Sadeghipour

Luis Ortega-Paz

Hessam Kakavand

Maryam Aghakouchakzadeh

...

2024/3/20

Diversity, equity, and inclusion in ASH guidelines

The Lancet Haematology

Matthew D Seftel

Deirdra Terrell

Adam Cuker

Matthew Cheung

Menaka Pai

2024/5/1

Laboratory monitoring of heparin anticoagulation in hemodialysis: Rationale and strategies

Thita Chiasakul

François Mullier

Thomas Lecompte

Philippe Nguyen

Adam Cuker

2024/1/30

Cost-effectiveness of rapid vs. in-house vs. send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura

Blood Advances

Cecily Allen

Satoko Ito

Ayesha Butt

Adriana Purcell

Rhys Richmond

...

2024/3/19

Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice

Blood Advances

Adam Cuker

Robert Kunkle

Rachel S Bercovitz

Michael Byrne

Benjamin Djulbegovic

...

2024/4/22

Effectiveness and Safety of Prophylactic Anticoagulation among Hospitalized Inflammatory Bowel Disease Patients

Blood Advances

Ghadeer K Dawwas

Adam Cuker

Douglas E Schaubel

James D Lewis

2024/1/1

Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper

Thrombosis and Haemostasis

Job Harenberg

Robert C Gosselin

Adam Cuker

Cecilia Becattini

Ingrid Pabinger

...

2024/3/8

Cost-effectiveness of prophylaxis with recombinant versus plasma-derived VWF in severe von Willebrand disease in the US

Blood Journal

Christina Waldron

Satoko Ito

Daniel Wang

Cecily Allen

Giri Viswanathan

...

2024/4/18

Combining Super Learner with high‐dimensional propensity score to improve confounding adjustment: A real‐world application in chronic lymphocytic leukemia

Pharmacoepidemiology and Drug Safety

Neil Dhopeshwarkar

Wei Yang

Sean Hennessy

Joanna M Rhodes

Adam Cuker

...

2024/1

The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysis

Haemophilia

Keerthy Joseph

Adam Cuker

Skye Peltier

Mark T Reding

Dunlei Cheng

...

2024/2/22

Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with …

Journal of Thrombosis and Haemostasis

Antonius MHP van den Besselaar

Anne Stavelin

Steve Kitchen

Michelle Bryant

Armando Tripodi

...

2024/4/1

Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity …

A Cuker

EK Tseng

R Nieuwlaat

2023

Documentation of menstrual concerns in women with inherited bleeding disorders: A single Center retrospective cohort study.

Journal of Obstetrics and Gynaecology Canada: JOGC= Journal D'obstetrique et Gynecologie du Canada: JOGC

Ximena A van Tienhoven

Allyson M Pishko

Elaine Chiang

Adam Cuker

Ariela L Marshall

2023/5/18

Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence

Annals of Hematology

Adam Cuker

Brian Buckley

Marie-Catherine Mousseau

Aditya Anand Barve

Jens Haenig

...

2023/8

OC 15.1 A Novel Point-of-Care Whole Blood Portable Analyzer for Direct Oral Anticoagulant Monitoring

Research and Practice in Thrombosis and Haemostasis

A Cuker

M Santiago

I Tubia

I Mijangos

T Montes

2023/10/1

Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States

Blood

Satoko Ito

Daniel Wang

Adriana Purcell

Karthik Chetlapalli

Alfred I Lee

...

2023/11/28

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

British journal of cancer

Anthony B El-Khoueiry

James Clarke

Tobias Neff

Tim Crossman

Nirav Ratia

...

2023/8/10

See List of Professors in Adam Cuker University(University of Pennsylvania)

Co-Authors

H-index: 133
Mark Crowther

Mark Crowther

McMaster University

H-index: 97
george m anderson

george m anderson

Yale University

H-index: 89
Nigel Key

Nigel Key

University of North Carolina at Chapel Hill

H-index: 82
Matthew State

Matthew State

University of California, San Francisco

H-index: 59
Alasdair Coles

Alasdair Coles

University of Cambridge

H-index: 56
Wei (Peter) Yang

Wei (Peter) Yang

University of Pennsylvania

academic-engine